Fluorodopa Pet

Fluorodopa PET is a positron emission tomography imaging technique that utilizes radiolabeled L-dihydroxyphenylalanine to selectively visualize and localize neuroendocrine tumors, particularly those of neural crest origin such as pheochromocytomas, by targeting their enhanced catecholamine synthesis pathway.

294

Publications

23K

Citations

1.5K

Authors

454

Institutions

Publications per year

2017–2026

42

Variants

18F-dopa PetFluorodopa Positron Emission Tomography

Authors

1.5K

  1. PC
    Paul Cumming

    Ludwig-Maximilians-Universität München, Germany

    15 publications · 925 citations

    15

    h-index

  2. DT
    David Taïeb

    Aix-Marseille Université, France

    15 publications · 959 citations

    14

    h-index

  3. KP
    Karel Pacák

    National Institutes of Health, United States

    14 publications · 1.5K citations

    13

    h-index

  4. CC
    Clara C. Chen

    National Institutes of Health, United States

    13 publications · 2.3K citations

    13

    h-index

  5. JA
    Jorge A. Carrasquillo

    National Institutes of Health, United States

    12 publications · 1.8K citations

    12

    h-index

1–5 of 1.5K

Venues

  1. PubMed

    Repository · 24 publications · 1.4K citations

    20

    h-index

  2. Annals of Neurology

    16 publications · 4.1K citations

    16

    h-index

  3. Journal of Cerebral Blood Flow & Metabolism

    15 publications · 895 citations

    14

    h-index

  4. 14

    h-index

  5. Movement Disorders

    12 publications · 1K citations

    12

    h-index

1–5